Yifan Xinfu Pharmaceutical Co Ltd (002019) — Capital Reinvestment Ratio
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Capital Reinvestment Ratio of 4.60x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥40.18 Million) in capital expenditures (CN¥184.68 Million). Check Yifan Xinfu Pharmaceutical Co Ltd (002019) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yifan Xinfu Pharmaceutical Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Yifan Xinfu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 21 annual periods. For the full cash flow conversion analysis, see Yifan Xinfu Pharmaceutical Co Ltd (002019) cash conversion ratio.
Annual Capital Reinvestment Ratio for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. See free cash flow generation of Yifan Xinfu Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | CN¥458.37 Million | CN¥559.23 Million | ▲ +24.4% |
| 2024 | 0.98x | CN¥640.73 Million | CN¥628.16 Million | ▼ -32.2% |
| 2023 | 1.45x | CN¥348.58 Million | CN¥504.09 Million | ▲ +25.9% |
| 2022 | 1.15x | CN¥472.07 Million | CN¥542.27 Million | ▼ -39.5% |
| 2021 | 1.90x | CN¥301.23 Million | CN¥571.74 Million | ▲ +194.0% |
| 2020 | 0.65x | CN¥1.11 Billion | CN¥715.71 Million | ▼ -30.1% |
| 2019 | 0.92x | CN¥937.24 Million | CN¥866.07 Million | ▲ +48.4% |
| 2018 | 0.62x | CN¥1.17 Billion | CN¥729.21 Million | ▲ +45.2% |
| 2017 | 0.43x | CN¥1.13 Billion | CN¥485.86 Million | ▲ +27.7% |
| 2016 | 0.34x | CN¥855.85 Million | CN¥287.50 Million | ▼ -37.8% |
| 2015 | 0.54x | CN¥401.96 Million | CN¥217.15 Million | ▼ -15.7% |
| 2014 | 0.64x | CN¥139.74 Million | CN¥89.51 Million | ▼ -70.3% |
| 2013 | 2.15x | CN¥34.32 Million | CN¥73.95 Million | ▼ -4.8% |
| 2012 | 2.26x | CN¥29.88 Million | CN¥67.64 Million | ▼ -12.3% |
| 2009 | 2.58x | CN¥58.61 Million | CN¥151.27 Million | ▲ +75.6% |
| 2008 | 1.47x | CN¥83.31 Million | CN¥122.46 Million | ▲ +112.5% |
| 2007 | 0.69x | CN¥248.71 Million | CN¥172.06 Million | ▼ -60.8% |
| 2006 | 1.77x | CN¥32.62 Million | CN¥57.62 Million | ▼ -27.3% |
| 2005 | 2.43x | CN¥24.12 Million | CN¥58.63 Million | ▲ +16.4% |
| 2004 | 2.09x | CN¥33.59 Million | CN¥70.14 Million | ▼ -49.6% |
| 2003 | 4.14x | CN¥12.65 Million | CN¥52.44 Million | — |